1509 studies found for:    rituximab
Show Display Options
Rank Status Study
1 Withdrawn Rituximab for GVHD
Conditions: Graft vs Host Disease;   Alogenic Hematopoietic Transplant
Intervention: Drug: Rituximab
2 Completed Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab
Conditions: Humoral Acute Refection of Renal Transplant;   Autoimmune Diseases
Interventions: Drug: Rituximab 375;   Drug: rituximab 1000
3 Unknown  Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Conditions: Follicular Lymphoma;   Marginal Zone B-Cell Lymphoma;   MALT Lymphoma;   Lymphoma of Mucosa-Associated Lymphoid Tissue;   Lymphoma, Small Lymphocytic;   Waldenstrom Macroglobulinemia;   Mantle-Cell Lymphoma
Interventions: Drug: lenalidomide-low dose dexamethasone plus rituximab;   Drug: Lenalidomide + Rituximab
4 Terminated
Has Results
Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia
Conditions: Leukemia;   Acute Lymphoblastic Leukemia;   ALL
Intervention: Drug: rituximab
5 Not yet recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Rituximab;   Drug: Placebo
6 Active, not recruiting Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: Fludarabine;   Drug: Novantrone;   Drug: Decadron;   Drug: Rituximab;   Drug: Interferon;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Ara-C;   Drug: Methyl-Prednisolone;   Drug: Procarbazine;   Drug: Prednisone
7 Not yet recruiting A Study of Ibrutinib Plus Rituximab With Hyper-CVAD Consolidation in Newly Diagnosed Young Patients With Mantle Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Ibrutinib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Dexamethasone;   Drug: Mesna;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: G-CSF;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Citrovorum
8 Completed
Has Results
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Conditions: Anemia, Aplastic;   Red-Cell Aplasia, Pure;   Anemia, Diamond-Blackfan
Intervention: Drug: Rituximab
9 Active, not recruiting A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Rituximab;   Drug: Lenalidomide;   Drug: Rituximab - CHOP;   Drug: Rituximab - CVP;   Drug: Rituximab - Bendamustine
10 Recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma
Conditions: Follicular Lymphoma;   B-cell Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Ibrutinib;   Drug: rituximab
11 Active, not recruiting Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
Condition: Lymphoma
Interventions: Drug: Bendamustine;   Drug: Bortezomib;   Drug: Rituximab
12 Terminated Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
Conditions: Grafting;   Renal Transplantation;   Transplantation, Kidney;   Chronic Allograft Nephropathy
Intervention: Drug: MabThera
13 Completed
Has Results
A Study to Evaluate Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Folate;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Placebo;   Drug: Rituximab
14 Completed Rituximab to Treat Stiff Person Syndrome
Condition: Stiff Person Syndrome
Interventions: Drug: Rituximab;   Drug: rituximab or placebo
15 Recruiting Intrathecal Rituximab in Lymphoid Malignancies Involving Central Nervous System
Conditions: Leukemia;   Lymphoid Malignancies;   Metastatic Malignant Neoplasm to the Leptomeninges
Intervention: Drug: Intrathecal Rituximab
16 Recruiting Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: rituximab
17 Active, not recruiting Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus
Condition: Pemphigus Disease
Intervention: Drug: General Corticotherapy
18 Unknown  Rituximab Trial for Pediatric Nephrotic Syndrome
Conditions: Steroid Resistant Nephrotic Syndrome;   Steroid Dependent Nephrotic Syndrome
Interventions: Drug: Rituximab;   Drug: Placebo
19 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
20 Active, not recruiting A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)
Condition: Diffuse Large B Cell Lymphoma
Interventions: Drug: LBH589;   Drug: Rituximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years